A single night without deep sleep can be enough to raise levels of a brain protein tied to Alzheimer’s disease, according to research using brain imaging in healthy adults. The protein, beta-amyloid, is the same substance that clumps together to form the plaques found in the brains of people with Alzheimer’s, and scientists have spent more than a decade trying to understand how the sleep-wake cycle affects how much of it accumulates. The emerging picture is that deep, slow-wave sleep is not passive rest for the brain but an active clearance period, and skipping it even once appears to leave more of the protein behind.
The PET Scan Study Behind The Finding
The key evidence comes from a study published in the Proceedings of the National Academy of Sciences, in which researchers scanned the brains of 20 healthy adults, ages 22 to 72, using positron emission tomography. Each participant was scanned once after a full night of normal sleep and once after a night of forced sleep deprivation. The comparison found a significant increase in beta-amyloid in the right hippocampus and thalamus, two regions involved in memory, after the sleepless night. The increases tracked with participants’ worsening mood following deprivation, though they were not linked to whether a participant carried the APOE gene variant associated with higher genetic risk for Alzheimer’s.
The study involved a small group and measured brain amyloid using imaging rather than a blood test or biopsy, which is why researchers describe the result as preliminary evidence rather than definitive proof of long-term harm from one bad night. Even so, it was among the first studies to show, in living human brains rather than in animal models, that acute sleep loss produces a measurable shift in a protein directly implicated in Alzheimer’s disease. The hippocampus and thalamus, the two regions where the increase showed up most clearly, are both involved in forming and consolidating memories, which is part of why researchers consider the location of the change, not just its existence, significant.
Why Deep Sleep Functions As Brain Cleanup
The mechanism researchers point to involves the glymphatic system, a network that flushes metabolic waste, including beta-amyloid, out of brain tissue primarily during deep, slow-wave sleep. During this stage, brain cells appear to shrink slightly, widening the channels through which cerebrospinal fluid flows and washes away waste proteins. Soluble beta-amyloid rises during ordinary wakefulness and falls during non-rapid eye movement sleep, with the clearance effect concentrated in the deepest stage of that cycle, known as slow-wave or stage 3 sleep. Interrupting or shortening that stage, even for a single night, appears to blunt the clearance process before it finishes.
Slow-wave sleep typically makes up a relatively small share of total sleep time and tends to shrink further with age, which researchers studying the sleep-Alzheimer’s link say may partly explain why amyloid buildup accelerates later in life. Alcohol, certain medications, and untreated sleep disorders such as sleep apnea can all reduce the amount of slow-wave sleep a person gets on a given night, even if total time in bed looks normal.
What Longer-Term Studies Add
Beyond single-night deprivation, the National Institute on Aging has funded research tracking sleep quality over years rather than nights. One study found that cognitively healthy adults whose sleep quality declined during middle age were more likely, decades later, to show a buildup of Alzheimer’s-related proteins in the brain than those whose sleep stayed stable or improved, according to NIA-funded findings. Related research has also linked excessive daytime sleepiness, a common sign of poor or insufficient deep sleep, to nearly three times the odds of elevated brain amyloid in older adults, reinforcing the idea that disrupted sleep architecture, not just short total sleep time, tracks with the buildup.
Researchers involved in these longer studies have proposed that middle age may represent a “window of sensitivity,” a period when treating sleep problems could plausibly slow the buildup of Alzheimer’s-related proteins, though that idea has not yet been tested in a large clinical trial designed to prove it changes disease outcomes.
What The Evidence Does Not Establish
Researchers are careful to note what a single night of lost deep sleep does not prove. The PET-scan study involved a small sample and measured a temporary spike in amyloid after one deprived night, not a permanent increase or a diagnosis of disease. Beta-amyloid levels are known to fluctuate with the sleep-wake cycle in everyone, and clearance can catch up once normal sleep resumes. The finding is better read as evidence that sleep architecture, and deep sleep specifically, plays an active role in a process implicated in Alzheimer’s risk over many years, rather than proof that missing one night of sleep causes the disease. Researchers studying the link continue to treat chronic, repeated disruption of deep sleep, not an isolated bad night, as the pattern most relevant to long-term risk.
This article was produced with the assistance of AI and reviewed by Morning Overview editors.
More from Morning Overview
